PAMU
ANIP icon

Pictet Asset Management (UK)’s ANI Pharmaceuticals ANIP Stock Holding History

Pictet Asset Management (UK)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-51,553
Closed -$1.67M – 1563
2020
Q2 		$1.67M Sell
51,553
-5,700
-10% -$204K ﹤0.01% 879
2020
Q1 		$2.33M Buy
57,253
+41,200
+257% +$2.19M 0.01% 829
2019
Q4 		$990K Sell
16,053
-1,500
-9% -$99.4K ﹤0.01% 988
2019
Q3 		$1.28M Buy
17,553
+1,300
+8% +$97.3K ﹤0.01% 902
2019
Q2 		$1.34M Buy
+16,253
New +$1.16M ﹤0.01% 899

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.66B AUM 6.69% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return